Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Research Library

ACE-083 research

6 articles to explore, with links to 5 original sources.

About ACE-083

ACE-083 is a follistatin-derived fusion protein used in laboratory research on locally acting muscle-regulatory pathways.

Understand the science

  • How the fusion protein was designed to stay local

    ACE-083 is an engineered fusion protein containing human FST291, a form of follistatin, joined to the Fc region of human IgG2. An older 2019 study looked at two kinds of binding that mattered for the design.

    1 source (2019)

Explore study findings

  • What the Charcot-Marie-Tooth trial learned from the ankle

    ACE-083 is a larger engineered protein that combines a form of follistatin with an antibody Fc region. It was investigated for local muscle growth.

    1 source (2022)

  • What healthy volunteers revealed about a local effect

    ACE-083 is a larger follistatin-based fusion protein developed to trap signals in the tissue where it was placed. Its 2018 first-in-human study asked how healthy volunteers tolerated it and whether a selected muscle changed in volume.

    2 sources (2018, 2022)

  • What mouse models could reveal about contraction

    ACE-083 is a larger engineered follistatin fusion protein built to capture several growth-regulating proteins locally. A 2019 animal study asked whether muscle enlargement after ACE-083 came with a change in the force that the same muscle could produce.

    2 sources (2019, 2022)

Check methods and identity

  • What newer muscle imaging adds to the ACE-083 story

    ACE-083 is a larger engineered fusion protein made from modified follistatin and the Fc region of a human antibody. It was designed to capture signals that restrict muscle growth near the muscle under study.

    2 sources (2022, 2026)

Interpret the evidence

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice.